ArticleClinical pharmacokinetics2026
Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10‑Year‑Old Patients with Paediatric Inflammatory Bowel Disease: Label‑Recommended Dose Fails to Achieve Therapeutic Target Concentration.
Q Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.